Neuropharmacological properties of some substituted gamma-butyrolactones.
D000679:Amygdala / Q000187:drug effects; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001535:Benactyzine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002415:Cats; D002552:Cerebral Ventricles; D004569:Electroencephalography; D005260:Female; D005663:Furans / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D007267:Injections; D007783:Lactones / Q000494:pharmacology*; D008032:Limbic System / Q000187:drug effects; D008297:Male; D008723:Methohexital / Q000494:pharmacology; D010546:Perphenazine / Q000494:pharmacology; D014149:Tranquilizing Agents / Q000494:pharmacology*
D005663:Furans; D006993:Hypnotics and Sedatives; D007783:Lactones; D014149:Tranquilizing Agents; D001535:Benactyzine; D008723:Methohexital; D010546:Perphenazine